Strategies for Optimizing Radiation Therapy for Small Cell Lung Cancer.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 23, doi. 10.1177/1559897715588458
- By:
- Publication type:
- Article
Works matching IS 15598977 AND DT 2015 AND VI 15 AND IP 8
Results: 21
1
2
Immunotherapy Is Evolving and Promising for Lung Cancer.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 28, doi. 10.1177/1559897715588457
- By:
- Publication type:
- Article
3
European Society for Medical Oncology, ELCC 2015 European Lung Cancer Conference: Advisor’s Introduction.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. i, doi. 10.1177/1559897715588541
- By:
- Publication type:
- Article
4
SBRT as Effective Treatment Option for Medically Operable Stage I NSCLC.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 18, doi. 10.1177/1559897715588495
- By:
- Publication type:
- Article
5
Prognostic Factors Identified in Stage IV NSCLC.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 16, doi. 10.1177/1559897715588466
- By:
- Publication type:
- Article
6
Malignant Pleural Mesothelioma: Genomic Landscape, Surgery, and Treatment Options.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 25, doi. 10.1177/1559897715588465
- By:
- Publication type:
- Article
7
ASSESS: EGFR Mutations Can Be Analyzed With ctDNA.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 7, doi. 10.1177/1559897715588497
- By:
- Publication type:
- Article
8
Novel Compound Beneficial as Adjunct to Antibody-Based Therapy for Stage IV NSCLC Patients.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 14, doi. 10.1177/1559897715588496
- By:
- Publication type:
- Article
9
TIME Trial: Efficacy of TG4010 Immunotherapy With First-Line Chemotherapy in NSCLC.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 11, doi. 10.1177/1559897715588311
- By:
- Publication type:
- Article
10
ESTERN: Neoadjuvant Erlotinib Showed Promise in NSCLC Patients With EGFR Mutations.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 10, doi. 10.1177/1559897715588305
- By:
- Publication type:
- Article
11
Gemcitabine Switch Maintenance Superior to Supportive Care in Advanced NSCLC.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 6, doi. 10.1177/1559897715588304
- By:
- Publication type:
- Article
12
LUX-Lung 5: Afatinib Plus Paclitaxel Improves Outcomes for Metastatic NSCLC.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 13, doi. 10.1177/1559897715588299
- By:
- Publication type:
- Article
13
Age-Stratified Subgroup Analysis of SQUIRE in Patients With Stage IV Squamous NSCLC.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 14, doi. 10.1177/1559897715588298
- By:
- Publication type:
- Article
14
Veliparib Plus Platinum Therapy Promising in NSCLC Phase 2 Trial.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 11, doi. 10.1177/1559897715588285
- By:
- Publication type:
- Article
15
Factors Affecting Use of PORT, Induction Chemotherapy, and Surgery to Improve Outcomes in NSCLC.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 20, doi. 10.1177/1559897715588278
- By:
- Publication type:
- Article
16
ARCHER 1009 Subset Analysis and LUX-8 Lung: Erlotinib Compared With Dacomitinib or Afatinib.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 5, doi. 10.1177/1559897715588077
- By:
- Publication type:
- Article
17
Hints of Better Survival With Surgery Than Radiation Therapy in Stage I NSCLC.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 8, doi. 10.1177/1559897715588076
- By:
- Publication type:
- Article
18
The Road to Patient-Based Therapy for NSCLC.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 2, doi. 10.1177/1559897715588070
- By:
- Publication type:
- Article
19
ALTER0302: Anlotinib Increased PFS as Third-Line Treatment for Refractory Advanced NSCLC.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 16, doi. 10.1177/1559897715588063
- By:
- Publication type:
- Article
20
Platinum-Plus Regimens Equally Effective First Therapies for EGFR Wild-Type NSCLC.
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 18, doi. 10.1177/1559897715588049
- By:
- Publication type:
- Article
21
Diffusion-Weighted Imaging: Superior to FDG-PET at Identifying Pulmonary Malignancy?
- Published in:
- MD Conference Express, 2015, v. 15, n. 8, p. 9, doi. 10.1177/1559897715587895
- By:
- Publication type:
- Article